Belinostat (PXD101) is experimental drug candidate under development by TopoTarget for the treatment of hematological malignancies and solid tumors. It is a histone deacetylase inhibitor. In 2007 preliminary results were released from the Phase II clinical trial of intravenous belinostat in combination with carboplatin and paclitaxel for relapsed ...
Found on
http://en.wikipedia.org/wiki/Belinostat
A substance being studied in the treatment of cancer. Belinostat blocks enzymes needed for cell division and may kill cancer cells. It also prevents the growth of blood vessels needed for tumors to grow and may make tumor cells more sensitive to other anticancer drugs. It is a type of histone deacetylase (HDAC) inhibitor, a type of angiogenesis inh...
Found on
http://www.cancer.gov/dictionary?expand=B
No exact match found.
